HomePPCB • NASDAQ
add
Propanc Biopharma Inc
Previous close
$0.19
Day range
$0.19 - $0.20
Year range
$0.16 - $9.36
Market cap
3.05M USD
Avg Volume
2.34M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.65M | 1,612.77% |
Net income | -3.09M | -618.62% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.65M | -1,613.25% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 561.24K | 3,735.42% |
Total assets | 15.11M | 19,142.27% |
Total liabilities | 3.66M | -13.64% |
Total equity | 11.45M | — |
Shares outstanding | 15.86M | — |
Price to book | 0.25 | — |
Return on assets | -55.23% | — |
Return on capital | -67.29% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -3.09M | -618.62% |
Cash from operations | -999.14K | -5,434.72% |
Cash from investing | -2.27K | — |
Cash from financing | 965.10K | 1,660.62% |
Net change in cash | -41.50K | -873.53% |
Free cash flow | -1.18M | -644.38% |
About
Founded
2007
Website
Employees
2
